Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1200/JCO.2019.37.15\_suppl.e16075
dc.identifier.other
WOS:000487345801503
dc.description.volume
dc.description.issue
Publisher
AMER SOC CLINICAL ONCOLOGY
DOI
10.1200/JCO.2019.37.15\_suppl.e16075
Abstract
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, MAY 31-JUN 04, 2019